Long-QT Syndrome From Genetics to Management

被引:449
作者
Schwartz, Peter J. [1 ,2 ,3 ,4 ,5 ]
Crotti, Lia [2 ,6 ]
Insolia, Roberto [2 ]
机构
[1] Univ Pavia, Fdn IRCCS Policlin S Matteo, Dept Mol Med, I-27100 Pavia, Italy
[2] Fdn IRCCS Policlin S Matteo, Dept Cardiol, I-27100 Pavia, Italy
[3] Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Res Africa, Cardiovasc Genet Lab, ZA-7925 Cape Town, South Africa
[4] Univ Stellenbosch, Dept Med, ZA-7600 Stellenbosch, South Africa
[5] King Saud Univ, Coll Med, Dept Family & Community Med, Chair Sudden Death, Riyadh 11461, Saudi Arabia
[6] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany
基金
美国国家卫生研究院;
关键词
arrhythmia (heart rhythm disorders); beta-blockers; genetics; long-QT syndrome; sudden death; CARDIAC SYMPATHETIC DENERVATION; BETA-BLOCKER THERAPY; COMPOUND MUTATIONS; SCN5A MUTATIONS; MOLECULAR-BASIS; HEART-RATE; T-WAVE; RISK; ARRHYTHMIA; PHENOTYPE;
D O I
10.1161/CIRCEP.111.962019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:868 / 877
页数:10
相关论文
共 75 条
[1]   MOLECULAR MECHANISM FOR AN INHERITED CARDIAC-ARRHYTHMIA [J].
BENNETT, PB ;
YAZAWA, K ;
MAKITA, N ;
GEORGE, AL .
NATURE, 1995, 376 (6542) :683-685
[2]   Nadolol Block of Nav1.5 Does Not Explain Its Efficacy in the Long QT Syndrome [J].
Besana, Alessandra ;
Wang, Dao W. ;
George, Alfred L., Jr. ;
Schwartz, Peter J. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (03) :249-253
[3]   Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population [J].
Brink, PA ;
Crotti, L ;
Corfield, V ;
Goosen, A ;
Durrheim, G ;
Hedley, P ;
Heradien, M ;
Geldenhuys, G ;
Vanoli, E ;
Bacchini, S ;
Spazzolini, C ;
Lundquist, AL ;
Roden, DM ;
George, AL ;
Schwartz, PJ .
CIRCULATION, 2005, 112 (17) :2602-2610
[4]   Of founder populations, long QT syndrome, and destiny [J].
Brink, Paul A. ;
Schwartz, Peter J. .
HEART RHYTHM, 2009, 6 (11) :S25-S33
[5]   β-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome [J].
Chatrath, R ;
Bell, CM ;
Ackerman, MJ .
PEDIATRIC CARDIOLOGY, 2004, 25 (05) :459-465
[6]   Mutation of an A-kinase-anchoring protein causes long-QT syndrome [J].
Chen, Lei ;
Marquardt, Michelle L. ;
Tester, David J. ;
Sampson, Kevin J. ;
Ackerman, Michael J. ;
Kass, Robert S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20990-20995
[7]  
Chockalingam P, J AM COLL C IN PRESS
[8]   Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery [J].
Collura, Christopher A. ;
Johnson, Jonathan N. ;
Moir, Christopher ;
Ackerman, Michael J. .
HEART RHYTHM, 2009, 6 (06) :752-759
[9]   KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome [J].
Crotti, L ;
Lundquist, AL ;
Insolia, R ;
Pedrazzini, M ;
Ferrandi, C ;
De Ferrari, GM ;
Vicentini, A ;
Yang, P ;
Roden, DM ;
George, AL ;
Schwartz, PJ .
CIRCULATION, 2005, 112 (09) :1251-1258
[10]   The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds:: Toward a mutation-specific risk stratification [J].
Crotti, Lia ;
Spazzolini, Carla ;
Schwartz, Peter J. ;
Shimizu, Wataru ;
Denjoy, Isabelle ;
Schulze-Bahr, Eric ;
Zaklyazminskaya, Elena V. ;
Swan, Heikki ;
Ackerman, Michael J. ;
Moss, Arthur J. ;
Wilde, Arthur A. M. ;
Horie, Minoru ;
Brink, Paul A. ;
Insolia, Roberto ;
De Ferrari, Gaetano M. ;
Crimi, Gabriele .
CIRCULATION, 2007, 116 (21) :2366-2375